Mark D. Stolper
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark D. Stolper
Mark D. Stolper is recorded as Board Member at Starling Oncology, Inc. (STLN). Starling Oncology, Inc. reported in an 8-K filed January 7, 2026 that Mark D. Stolper was appointed Director, effective January 2, 2026.
“effective January 2, 2026, the Board of Directors (the “Board”) of The Oncology Institute, Inc. (the “Company”) filled a vacancy on the Board by appointing Mark D. Stolper to the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Starling Oncology, Inc. (STLN)
SEC 8-K
Current2026-01-02–present
-
Current
2026-01-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Starling Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Virnich CEO, COO, Board Member
- Anne McGeorge Chairman
- Brad Hively Chairman
- Robert Carter CFO, Chief Accounting Officer
- Dr. Matt Miller COO
- Jeremy N. Castle COO
- Mark Huppelsheuser General Counsel
- Dr. Gregory Sorensen Board Member
- Dr. Jennifer Carter Board Member
- Dr. Mohit Kaushal Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.